₇Susumu Furukawa

Summary for 2006 [at-glance overview of Susumu Furukawa work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Susumu Furukawa. According to available data, in 2006 Susumu Furukawa published at least 7 articles. This work was completed in collaboration with several authors including Ichiyama, Takashi and Matsubara, Tomoyo. Many other authors have collaborated with Susumu Furukawa as well. There is no information about the funding or the grants awarded to support this work.

Susumu Furukawa has rank 277 when compared to all other authors using the keyword Cytokines. Analysis of the article abstracts and the titles suggests that Susumu Furukawa professional interests are focused around "acute disseminated encephalomyelitis", "levels sspe patients" and "levels acute stage". These might also be referred to as "cerebrospinal fluid", "disseminated encephalomyelitis" or "acute disseminated". Statistical analysis shows that Susumu Furukawa's writing is likely to contains terms "levels", "serum", "patients", "acute", "csf" and "mmp-9".

The majority of Susumu Furukawa articles are affiliated with Department of Pediatrics, Yamaguchi University School of Medicine, 1-1-1 Minami-kogushi, Minamikogushi, Ube, Yamaguchi. 755-8505, Yamaguchi, Japan, 755-8505, Japan. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Susumu Furukawa]

Do you know Susumu Furukawa who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Susumu Furukawa]

₁₆₄Furukawa, S

Year 2006 Charts [Susumu Furukawa frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Susumu Furukawa publication and funding history for the range of years]

Emails (2) [email addresses extracted from Susumu Furukawa affiliations]

hidden to prevent spam, click here to reveal

Susumu Furukawa Coauthors (24) [all coauthors with the number of joint publications]

7

3

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

Affiliations (4) [condensed summary of the Susumu Furukawa affiliations, the leading number and the color conveys importance]

₄Department of Pediatrics, Yamaguchi University School of Medicine, 1-1-1 Minami-kogushi, Minamikogushi, Ube, Yamaguchi. 755-8505, Yamaguchi, Japan, 755-8505, Japan.
₁Department of Allergy, Yamaguchi University, School of Medicine, and Department of Hospital Pharmacy, Niigata City General Hospital, Japan.
₁Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.
₁Yamaguchi University School of Medicine, Japan.

Key Opinion Leader In [Susumu Furukawa is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₂₇₇Cytokines | ₇₀₄Infant | ₉₃₉Child, Preschool

Keywords (32) [keywords assigned to Susumu Furukawa articles by PubMed, the leading number and the color conveys importance]

₆Humans | ₆Male | ₄Infant | ₄Child, Preschool | ₃Cytokines | ₃Child | ₃Female | ₂Encephalomyelitis, Acute Disseminated | ₂Adolescent | ₁Foodborne Diseases | ₁Cerebrospinal Fluid Otorrhea | ₁Follow-Up Studies | ₁Ear, Inner | ₁Infusions, Intravenous | ₁Carrier Proteins | ₁Demyelinating Autoimmune Diseases, CNS | ₁Sialoglycoproteins | ₁Diazepam | ₁Electroencephalography | ₁Antirheumatic Agents | ₁Japan | ₁Case-Control Studies | ₁Antibodies, Anti-Idiotypic | ₁Receptors, Tumor Necrosis Factor | ₁Statistics, Nonparametric | ₁Enzyme-Linked Immunosorbent Assay | ₁Interleukin-6 | ₁Immunoglobulin G | ₁Ginkgo biloba | ₁Papua New Guinea | ₁Fever | ₁Exanthema

Susumu Furukawa Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Susumu Furukawa might be a good expert witness on these terms]

₁₉levels | ₁₉serum | ₁₃patients | ₁₂acute | ₁₀csf | ₁₀mmp-9 | ₁₀timp-1 | ₁₀stage | ₉sspe | ₉il-6 | ₉dexamethasone | ₉adem | ₈higher | ₈ivig | ₇case | ₆cerebrospinal | ₆fluid | ₆il-10 | ₆controls | ₆disseminated | ₆encephalomyelitis | ₅cytokine | ₅significantly | ₅human | ₅ifn-gamma | ₄inflammatory | ₄therapy | ₄patient | ₄brain | ₄treatment | ₃comparison | ₃kd
₆cerebrospinal fluid | ₆disseminated encephalomyelitis | ₆acute disseminated | ₆mmp-9 timp-1 | ₅sspe patients | ₅acute stage | ₄levels sspe | ₄significantly higher | ₄levels acute | ₄il-6 il-10 | ₄stage higher | ₄convalescent stage | ₄serum mmp-9 | ₄il-2 il-4 | ₃serum cerebrospinal | ₃papua guinea | ₃anti-inflammatory effect | ₃cytokine levels | ₃higher controls | ₃comparison dexamethasone | ₃inner ear | ₃neurologic cutaneous | ₃myoclonic jerks | ₃csf il-6 | ₃kawasaki disease | ₃cutaneous articular | ₃ifn-gamma tnf-alpha | ₃mondini dysplasia | ₃subacute sclerosing | ₃brain mri | ₃sclerosing panencephalitis | ₃infantile neurologic
₆acute disseminated encephalomyelitis | ₄levels sspe patients | ₄levels acute stage | ₄acute stage higher | ₃serum cerebrospinal fluid | ₃neurologic cutaneous articular | ₃stage higher convalescent | ₃serum il-6 il-10 | ₃il-6 il-10 levels | ₃subacute sclerosing panencephalitis | ₃higher convalescent stage | ₃infantile neurologic cutaneous | ₃chronic infantile neurologic | ₂severe case chronic | ₂chemokine profiles acute | ₂significantly higher without | ₂il-10 levels sspe | ₂timp-1 levels acute | ₂sspe patients significantly | ₂significantly higher controls | ₂fluid csf patients | ₂levels subacute sclerosing | ₂panencephalitis papua guinea | ₂case chronic infantile | ₂treated biologic agents | ₂vitro implication treatment | ₂comparison dexamethasone vitro | ₂cerebrospinal fluid csf | ₂articular syndrome treated | ₂fluid cytokine levels | ₂anti-inflammatory effect intravenous | ₂sclerosing panencephalitis papua

Reader's Comments (0) [comments posted by readers of Susumu Furukawa profile]